MC

Milenko Cicmil

Co-Founder and CEO of Tasca Therapeutics and Venture Partner at Cure Ventures

Boston, Massachusetts

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Visiting Research Fellow at Univ. of Reading, UK

    2020

  • Partner

    2021

2021 - 2022

  • Chairman Of The Board AMP Discovery

    2021 - 2022

2019 - 2021

  • Vice President Global Head of external Innovation

    2019 - 2021

2017 - 2019

  • Vice President - Translational Biology

    2017 - 2019

2013 - 2017

  • Director at Merck Innovation Hub

    2016 - 2017

  • Director Pharmacology Immuno-Oncology and Immunomodulation

    2013 - 2016

2011 - 2013

  • Director In vivo Pharmacology R&I

    2011 - 2013

2004 - 2011

  • Group Leader Integrative Pharmacology Discovery Bioscience - Inflammation

    2007 - 2011

  • Senior Research Scientist

    2004 - 2007

2002 - 2004

  • Senior Research Scientist

    2002 - 2004

2000 - 2002

  • Translational Science - Research Fellow

    2000 - 2002